Episode Thumbnail
Episode 115  |  30:59 min

Challenges with Pediatric Medical Devices

Episode 115  |  30:59 min  |  11.07.2019

Challenges with Pediatric Medical Devices

00:00
00:00
This is a podcast episode titled, Challenges with Pediatric Medical Devices. The summary for this episode is: Challenges continue with the design and development of pediatric medical devices. In this episode, Mike Drues of Vascular Sciences, and I discuss the lack of availability for such devices and prescription drugs, specifically with children in mind. Some of the highlights of the show include: ● Smaller versions of adult medical devices and drugs for pediatric population may not be the best solution or solve the problem. ● Lack of availability is due to lack of market. Drugs approved by the FDA for adults are relabeled for kids. ● Two-thirds of all drugs prescribed to children have not been studied or labeled specifically for them, and 90% of the drugs given to newborns are off-label. ● Physicians modify and improvise: Technical challenges include designing and developing pediatric-specific products that change and grow as the child does. ● How can industry get companies to focus on life-sustaining/life-saving devices and drugs for pediatric market? Clinical trials, informed consent, and 3D printing. ● Most medical products are required to show safety and efficacy; HDE only requires probable benefit. ● Real world evidence needed to support pediatric medical device submissions. ● Necessity is the Mother of Invention: Doctors retrofitted breathing tube for Saybie, a micro preemie the size of an apple.
Challenges continue with the design and development of pediatric medical devices. In this episode, Mike Drues of Vascular Sciences, and I discuss the lack of availability for such devices and prescription drugs, specifically with children in mind. Some of the highlights of the show include: ● Smaller versions of adult medical devices and drugs for pediatric population may not be the best solution or solve the problem. ● Lack of availability is due to lack of market. Drugs approved by the FDA for adults are relabeled for kids. ● Two-thirds of all drugs prescribed to children have not been studied or labeled specifically for them, and 90% of the drugs given to newborns are off-label. ● Physicians modify and improvise: Technical challenges include designing and developing pediatric-specific products that change and grow as the child does. ● How can industry get companies to focus on life-sustaining/life-saving devices and drugs for pediatric market? Clinical trials, informed consent, and 3D printing. ● Most medical products are required to show safety and efficacy; HDE only requires probable benefit. ● Real world evidence needed to support pediatric medical device submissions. ● Necessity is the Mother of Invention: Doctors retrofitted breathing tube for Saybie, a micro preemie the size of an apple.

More Episodes

Greenlight Guru Acquires CanvasGT: A Fire(less)side Chat

Greenlight Guru Acquires CanvasGT: A Fire(less)side Chat

Tips for Being Prepared Post-EUA (Emergency Use Authorization)

Tips for Being Prepared Post-EUA (Emergency Use Authorization)

Understanding the UDI System for Medical Devices

Understanding the UDI System for Medical Devices

Shaking Things Up: What's Next for the Global Medical Device Podcast

Shaking Things Up: What's Next for the Global Medical Device Podcast

How Augmented Reality (AR) is Revolutionizing Healthcare

How Augmented Reality (AR) is Revolutionizing Healthcare

Why FDA is Prioritizing Clinical Decision Support Software & Why You Should Care

Why FDA is Prioritizing Clinical Decision Support Software & Why You Should Care